Journal of Oral Health and Community Dentistry

Register      Login

VOLUME 7 , ISSUE 2 ( May-August, 2013 ) > List of Articles

REVIEW ARTICLE

Addressing Antimicrobial Resistance in Dentistry

BC Manjunath, BR Chandrashekar, RRM Vatchala, P Babaji, I Singh, K Arora, C Madan

Citation Information : Manjunath B, Chandrashekar B, Vatchala R, Babaji P, Singh I, Arora K, Madan C. Addressing Antimicrobial Resistance in Dentistry. J Oral Health Comm Dent 2013; 7 (2):101-107.

DOI: 10.5005/johcd-7-2-101

License: CC BY-NC 3.0

Published Online: 00-05-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Antimicrobial agents are life saving drugs which are used in management of various life threatening infections but irrational use of antibiotics have led to resurgence of multidrug resistant bacteria which are associated with global increase in mortality due to various infections. Dentists are one among important health care personnel who prescribe antibiotics routinely to treat various oral infections.

Objectives

To summarise the evidence of antimicrobial resistance (AMR) encountered in dental practice, discuss factors associated with it and suggest measures to prevent antimicrobial resistance in dentistry.

Methodology

Articles were identified by searching in electronic data bases such as PubMed, Medline, Embase, Google Scholar and Cochrane data bases using key words like antibiotics, antimicrobial resistance, and antibiotic resistance in dentistry. The articles fulfilling the objectives were included.

Results and Conclusions

Dentists also contribute significantly to the global burden of antimicrobial resistance due to irrational use of antibiotics. Antibiotic stewardship is essential to prevent antimicrobial resistance in dental practice and hence there is an urgent need to educate not only dentists but general public as well. The article describes the gravity of the AMR and the importance of prudent use of antibiotics is discussed.


PDF Share
  1. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. Influenzae. Br J Exp Pathol 1929;10:226–36.
  2. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10(9):597–602.
  3. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011;11(5):355–62.
  4. Antibiotic resistance: an editorial review with recommendations. J Drugs Dermatol 2011;10(7):724–33.
  5. World Health Organisation report on infectious diseases 2000. Cited on 2011 June 11 available from: http://www.who.int/infectious-disease-report/ 2000.
  6. World Health Day – 7 April 2011 Antimicrobial resistance: no action today, no cure tomorrow. Cited on 2011 April 15 Available from: http://www.who.int/world-health-day/2011/en/
  7. Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther 2010;8(12):1441–50.
  8. Antimicrobial resistance. Cited on 2011 April 20, available from: http://www.who.int/mediacentre/factsheets/fs194/en.
  9. A report from the American academy of microbiology. 2009, American Academy of Microbiology. Available from: http://academy.asm.org/images/stories/documents/antibioticresistance.pdf
  10. Combating antimicrobial resistance in India. JAMA 1999;281(12):1081–82.
  11. Emerging antibiotic resistance in bacteria with special reference to India. J Biosci 2008;33(4):593–603.
  12. New drug policy to curb misuse of antibiotics. Feb 18, 2011. Cited on 2011 May 21, available from: http://articles.timesofindia.indiatimes.com/2011-02-18/india/28614513_1_antibiotic-policy-new-drug-policy-prescription.
  13. Incidence of antibiotic prescribing in dental practice in Norway and its contribution to national consumption. J Antimicrob Chemother 2007;59(6):1161–66.
  14. Antimicrobial resistance: Dentistry's role. J Can Dent Assoc 1998;64(7):496–502.
  15. Antibiotic use in dental practice. A review. Med Oral Patol Oral Cir Bucal 2007;12(3):E186–92.
  16. A survey of antibiotic use in dentistry. J Am Dent Assoc 2000;131(11):1600–09.
  17. Antibiotic prescribing in dental practice in Belgium. Int Endod J 2009;42(12):1112–17.
  18. Human oral microbial ecology and dental caries and periodontal diseases. Crit Rev Oral Biol Med 1996;7(2):180–198.
  19. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43(11):5721–32.
  20. Penicillin-resistant streptococci from the saliva. J Dent Res 1966;45(2):243–48.
  21. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90(5):600–608.
  22. Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(2):186–92.
  23. Emergence of antibiotic resistant Streptococcus sanguis in dental plaque of children after frequent antibiotic therapy. Pediatr Dent 1999;21(3):181–85.
  24. Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2001;16(1):10–15.
  25. Beta-lactam resistance in anaerobic bacteria: a review. J Chemother 1996;8(1):3–16.
  26. Effect of amoxicillin use on oral microbiota in young children. Antimicrob Agents Chemother 2004;48(8):2883–2887.
  27. Prevalence and persistence of amoxycillin-resistant bacteria in the dental plaques of adults. Microbios 1999;100(397):135–144.
  28. Prevalence, proportions, and identities of antibiotic-resistant bacteria in the oral microflora of healthy children. Microb Drug Resist 2003;9(4):367–72.
  29. The problem of cephalosporins. J Antimicrob Chemother 2001;48:463–78.
  30. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics. Oral Microbiol Immunol 2002;17(5):285–89.
  31. High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. J Antimicrob Chemother 2001;47(1):87–91.
  32. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol 1997;24(11):804–07.
  33. Drugs information online; Drugs.com. Cited on 2011 May 15 available from: http://www.drugs.com/cons/penicillins-and-beta-lactamase-inhibitors.html.
  34. Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res 2010;45(4):557–63.
  35. Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain. Rev Esp Quimioter 2007;20(1):61–67.
  36. Clindamycin in dentistry: more than just effective prophylaxis for endocarditis? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100(5):550–58.
  37. Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections. J Chemother 2007;19(5):495–99.
  38. Antibiotics for acute orofacial infections. J Calif Dent Assoc 1993;21(2):34–44.
  39. Macrolide antibiotics. Dent Today 1997;16(11):72, 74-5,78-79.
  40. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob Agents Chemother 2000;44(4):1078–80.
  41. Tetracycline in the treatment of periodontal disease: review of current literature. J Am Dent Assoc 1980;101(6):935–36.
  42. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother 2003;47(3):878–82.
  43. Detection and incidence of the tetracycline resistance determinant tet(M) in the microflora associated with adult periodontitis. J Periodontol 1995;66(2):102–108.
  44. Detection and prevalence of the tetracycline resistance determinant Tet Q in the microbiota associated with adult periodontitis. Oral Microbiol Immunol 1996;11(4):282–88.
  45. The maintenance in the oral cavity of children of tetracycline-resistant bacteria and the genes encoding such resistance. J Antimicrob Chemother 2005; 56(3):524–31.
  46. Metronidazole: its use in clinical dentistry. J Clin Periodontol 1984;11(3):145–58.
  47. Antibiotic resistance of periodontal pathogens obtained from frequent antibiotic users. Acta Odontol Latinoam 2009;22(2):99–104.
  48. The use of systemic antibiotics in the treatment of aggressive periodontal disease. Gen Dent 2005;53(2):155–59.
  49. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol 2005;32(8):893–98.
  50. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001;80(3):903–08.
  51. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations. J Clin Microbiol 2000;38(4):1563–68.
  52. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002;46(6):1704–13.
  53. High incidence of meropenem resistance among alpha-hemolytic streptococci in children with cancer. Pediatr Int 2009;51(1):103–06.
  54. Mouthwashes. Aust Prescr 2009;32:162–64.
  55. Antiplaque biocides and bacterial resistance: a review. J Clin Periodontol 2002;29(11):965–74.
  56. The rationale for the daily use of an antimicrobial mouthrinse. J Am Dent Assoc 2006;137Suppl:16S–21S.
  57. Chlorhexidine compounds in cosmetic products, Risk assessment of antimicrobial and antibiotic resistance development in microorganisms. Opinion of the Panel on Biological Hazards of the Norwegian Scientific Committee for Food Safety: 15. April 2010. Cited on 2011 May 20 available from: http://www.vkm.no/dav/10b449dcc5.pdf.
  58. In vitro development of chlorhexidine resistance in Streptococcus sanguis and its transmissibility by genetic transformation. Scand J Dent Res 1980;88(3):236–43.
  59. Opinion on triclosan Antimicrobial Resistance The. European Union, 2010. Cited on 2011 June 17, available from: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_023.pdf.
  60. Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist 2006;12(2):83–90.
  61. Whither triclosan? J Antimicrob Chemother 2004;53(5):693–695.
  62. Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm 2009;66(12 Suppl 4):S15–22.
  63. Clinical use of antibiotics in dental practice. Int J Antimicrob Agents 1998;9(4):235–38.
  64. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2008;(4):CD003813.
  65. American dental association. http://www.ada.org . Cited on 2011 May 17 Available from: http://www.ada.org /2157.aspx#top
  66. Antibiotic prophylaxis in dentistry: a review and practice recommendations. J Am Dent Assoc 2000;131(3):366–74.
  67. Antibiotic Prophylaxis for Bacteremia in Patients with Joint Replacements. American association of orthopedic surgeons (AAOS). Cited on 2011 May 17 available from: http://www6.aaos.org/news/PDFopen/PDFopen.cfm?page_url=http://www.aaos.org/about/papers/advistmt/1033.asp.
  68. Antibiotic prescribing practices by South Australian general dental practitioners. Aust Dent J 2000;45(3):179–86.
  69. Pattern of antibiotic prescription in the management of oral diseases among dentists in Kuwait. J Dent 2004;32(7):503–09.
  70. Development of a rational antibiotic usage course for dentists. Eur J Dent Educ 2008;12(1):41–47.
  71. Management of odontogenic infection of pulpal and periodontal origin. Med Oral Patol Oral Cir Bucal 2007;12(2):154–59.
  72. Antibiotic resistance and antibiotics in endodontics. Clinical Update 2003;23(12):23–25.
  73. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance. Am Fam Physician 2001;64(6):999–1004.
  74. Combating antibiotic resistance. J Am Dent Assoc 2004;135:484–87.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.